Jonathan A. Hickson

1.2k total citations
28 papers, 888 citations indexed

About

Jonathan A. Hickson is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Jonathan A. Hickson has authored 28 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Pathology and Forensic Medicine and 10 papers in Oncology. Recurrent topics in Jonathan A. Hickson's work include Cancer Mechanisms and Therapy (7 papers), Melanoma and MAPK Pathways (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jonathan A. Hickson is often cited by papers focused on Cancer Mechanisms and Therapy (7 papers), Melanoma and MAPK Pathways (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jonathan A. Hickson collaborates with scholars based in United States, United Kingdom and Russia. Jonathan A. Hickson's co-authors include Carrie Rinker‐Schaeffer, Donald J. Vander Griend, S. Diane Yamada, Dezheng Huo, Anning Lin, Sarah F. Adams, Anthony Montag, Victoria Robinson, Tamara L. Lotan and Jonathan Berger and has published in prestigious journals such as Cancer Research, Cell Death and Differentiation and International Journal of Cancer.

In The Last Decade

Jonathan A. Hickson

28 papers receiving 872 citations

Peers

Jonathan A. Hickson
Cristina Basilico Italy
Andreas Enns Germany
Takehiro Nohara Japan
Carles Barceló Spain
Susanne Klein‐Scory Germany
Emily Chan United States
IR Hart United Kingdom
Ashwini A. Katre United States
Yuan Mao China
Frank Herting Switzerland
Cristina Basilico Italy
Jonathan A. Hickson
Citations per year, relative to Jonathan A. Hickson Jonathan A. Hickson (= 1×) peers Cristina Basilico

Countries citing papers authored by Jonathan A. Hickson

Since Specialization
Citations

This map shows the geographic impact of Jonathan A. Hickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Hickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Hickson more than expected).

Fields of papers citing papers by Jonathan A. Hickson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan A. Hickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Hickson. The network helps show where Jonathan A. Hickson may publish in the future.

Co-authorship network of co-authors of Jonathan A. Hickson

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan A. Hickson. A scholar is included among the top collaborators of Jonathan A. Hickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan A. Hickson. Jonathan A. Hickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hickson, Jonathan A., et al.. (2024). Abstract A002: Understanding mechanisms of resistance to WRN small molecule inhibitors. Molecular Cancer Therapeutics. 23(6_Supplement). A002–A002. 1 indexed citations
2.
Skaddan, Marc B., Dustin Wooten, Kyle C. Wilcox, et al.. (2022). [18F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton’s Tyrosine Kinase. Molecular Imaging and Biology. 24(5). 830–841. 3 indexed citations
3.
Bratcher, Natalie A., et al.. (2019). Effects of Buprenorphine in a Preclinical Orthotopic Tumor Model of Ovarian Carcinoma in Female CB17 SCID Mice. Journal of the American Association for Laboratory Animal Science. 58(5). 583–588. 4 indexed citations
4.
Purcell, James W., Jonathan A. Hickson, Melvin Fox, et al.. (2018). LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates. Cancer Research. 78(14). 4059–4072. 136 indexed citations
5.
Li, Yingchun, Jonathan A. Hickson, Deanna L. Haasch, et al.. (2018). ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models. Molecular Cancer Therapeutics. 17(5). 1039–1050. 35 indexed citations
6.
7.
Souris, Jeffrey S., et al.. (2013). Flexible peritoneal windows for quantitative fluorescence and bioluminescence preclinical imaging.. PubMed. 12(1). 28–38. 3 indexed citations
8.
Mudd, Sarah R., Martin J. Voorbach, David R. Reuter, et al.. (2012). FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model. Cancer Chemotherapy and Pharmacology. 69(6). 1669–1672. 4 indexed citations
9.
Thiolloy, Sophie, Tamara L. Lotan, Jonathan A. Hickson, et al.. (2010). In vitro metastatic colonization of human ovarian cancer cells to the omentum. Clinical & Experimental Metastasis. 27(3). 185–196. 47 indexed citations
10.
Hickson, Jonathan A., Scott Ackler, Dieter H. Klaubert, et al.. (2010). Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin. Cell Death and Differentiation. 17(6). 1003–1010. 50 indexed citations
11.
Hickson, Jonathan A.. (2009). In vivo optical imaging: Preclinical applications and considerations. Urologic Oncology Seminars and Original Investigations. 27(3). 295–297. 24 indexed citations
12.
Taylor, Jennifer, Russell Z. Szmulewitz, Tamara L. Lotan, et al.. (2008). New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. Cancer Letters. 272(1). 12–22. 19 indexed citations
13.
Hickson, Jonathan A., S. Diane Yamada, Jonathan Berger, et al.. (2008). Societal interactions in ovarian cancer metastasis: a quorum-sensing hypothesis. Clinical & Experimental Metastasis. 26(1). 67–76. 42 indexed citations
14.
Donawho, Cherrie K., Jonathan A. Hickson, Yichun Wang, et al.. (2007). The RTK inhibitor ABT-869, alone and in combination with paclitaxel and/or zoledronic acid, demonstrates significant reduction in the development of both osteoblastic (LuCap 23.1) and osteolytic (PC3-M-Luciferase) tumors intratibially. Molecular Cancer Therapeutics. 6. 2 indexed citations
15.
Donawho, Cherrie K., Yichun Wang, Gail Bukofzer, et al.. (2007). The RTK inhibitor, ABT-869 alone or in combination with various cytotoxic therapies demonstrate significant tumor growth inhibition in orthotopic hepatocellular carcinoma, renal cell carcinoma and prostate xenografts. Molecular Cancer Therapeutics. 6. 1 indexed citations
16.
Taylor, Jennifer L., Jonathan A. Hickson, Tamara L. Lotan, Diane Yamada, & Carrie Rinker‐Schaeffer. (2007). Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment. Cancer and Metastasis Reviews. 27(1). 67–73. 22 indexed citations
17.
Adams, Sarah F., et al.. (2006). PDGFR-α as a potential therapeutic target in uterine sarcomas. Gynecologic Oncology. 104(3). 524–528. 35 indexed citations
18.
Berger, Jonathan, Donald J. Vander Griend, Victoria Robinson, Jonathan A. Hickson, & Carrie Rinker‐Schaeffer. (2005). Metastasis suppressor genes: From gene identification to protein function and regulation. Cancer Biology & Therapy. 4(8). 805–812. 42 indexed citations
19.
Jaeger, Erich, Marina Chekmareva, Thelma R. Tennant, et al.. (2003). Inhibition of prostate cancer metastatic colonization by ∼4.2 Mb of human chromosome 12. International Journal of Cancer. 108(1). 15–22. 3 indexed citations
20.
Robinson, Victoria, Jonathan A. Hickson, Donald J. Vander Griend, Zita Dubauskas, & Carrie Rinker‐Schaeffer. (2003). MKK4 and metastasis suppression: A marriage of signal transduction and metastasis research. Clinical & Experimental Metastasis. 20(1). 25–30. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Basilico Breakdown of academic impact, for papers by Andreas Enns Breakdown of academic impact, for papers by Takehiro Nohara Breakdown of academic impact, for papers by Carles Barceló Breakdown of academic impact, for papers by Susanne Klein‐Scory Breakdown of academic impact, for papers by Emily Chan Breakdown of academic impact, for papers by IR Hart Breakdown of academic impact, for papers by Ashwini A. Katre Breakdown of academic impact, for papers by Yuan Mao Breakdown of academic impact, for papers by Frank Herting
Rankless by CCL
2026